The global brain disease modalities and software market is projected to reach $21.86 billion in terms of revenue by 2031 at a CAGR of 5.31%, reveals the premium market intelligence study by BIS Research.
The opportunity for growth of the global brain disease modalities and software market lies in the integration of imaging solutions with novel biomarkers to enable diagnosis of a wider range of neurological disorders and integration of 3D amplified MRI, a new technological advancement in the field of brain imaging.
The detailed study is a compilation of 46 Market Data Tables and 153 Figures spread through 245 Pages and in-depth TOC on “Global Brain Disease Modalities and Software Market – Analysis and Forecast, 2022-2031”
USP of the Report
This extensive report can help with:
- Aiding in the development of advanced imaging modalities and imaging software solutions.
- Aiding in understanding the regulatory scenario of the market in different regions.
- Aiding in understanding the patent trend of the market.
- Aiding in targeting end users for increasing the adoption of brain imaging modalities and software.
- Supporting in analyzing the market opportunities.
- Helping to understand the competitive positioning of the key companies in the market.
Analyst’s Take on the Market:
According to Swati Sood, Lead Analyst – BIS Research, “The global brain disease modalities and software market is expected to witness significant growth in emerging economies due to the rising technology integration in medical imaging as well as the rising preference for imaging software solutions for enhanced accuracy of diagnosis of neurological disorders.“
View the report from BIS Research on Global Brain Disease Modalities and Software Market
Key Companies Operating in the Market and Competition Landscape
Some of the key players operating in the market include United Imaging Healthcare, Koninklijke Philips N.V., General Electric Company, Canon Inc., Siemens Healthineers AG, Vuno Co., Ltd., Fujifilm Holdings Corporation, Aspect Imaging, IXICO, QMENTA, Cortechs.ai, Quantib, Brainomix, Qure.AI, Imaging Biometrics, and A.I. Analysis, Inc.
Get FREE Sample Report Here
Key Questions Answered in the Report:
- How has COVID-19 impacted the adoption of brain imaging modalities and software?
- What are the key regulations governing the brain disease modalities and software market in key regions?
- Which technological developments are projected to have the maximum influence on the global brain disease modalities and software market?
- Who are the leading players holding significant dominance in the global brain disease modalities and software market currently?
- What are the drivers and restraints for the global brain disease modalities and software market?
- Which region has the highest growth rate in the global brain disease modalities and software market?
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to AI-Techpark.com.
